Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Role of Nebulized Heparin in Non-severe and Severe Covid-19 Patients Admitted to COVID Complex LRH, MTI: A Randomized Controlled Trial

NCT05255848 is registered in ClinicalTrials.gov with Lady Reading Hospital, Pakistan as lead sponsor.

NCT NCT05255848
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05255848 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Role of Nebulized Heparin in Non-severe and Severe Covid-19 Patients Admitted to COVID Complex LRH, MTI: A Randomized Controlled Trial
Lead sponsor
Lady Reading Hospital, Pakistan
Phase
Phase 2/3
Overall status
Unknown status
Start date
June 20, 2022
Completion date
October 20, 2022
Enrollment
180 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19 pneumonia